Privia Health CEO Sells $3.11M in Shares

Parth Mehrotra reduces his ownership stake in the healthcare technology company by 4.47%

Mar. 17, 2026 at 8:19am

Privia Health Group, Inc. (NASDAQ:PRVA) CEO Parth Mehrotra sold 138,528 shares of the company's stock across several recent trades, reducing his ownership stake by 4.47% to 581,952 shares valued at about $12.52 million. The sales, which totaled roughly $3.11 million, came after Privia reported better-than-expected Q4 earnings and revenue.

Why it matters

Insider selling can sometimes signal a lack of confidence in a company's future prospects, though large sales by executives are not uncommon, especially after strong financial results. Privia's stock has seen volatility in recent months, and this transaction provides insight into the CEO's personal financial planning.

The details

Mehrotra sold the shares in five separate transactions between March 6 and March 13, with the average price per share ranging from $21.52 to $23.15. The sales reduced his direct ownership to about 581,952 shares, or 4.47% of the company's outstanding stock.

  • On March 6, Mehrotra sold 21,440 shares at $23.15 per share.
  • On March 9, Mehrotra sold 41,999 shares at $22.86 per share.
  • On March 10, Mehrotra sold 21,097 shares at $22.71 per share.
  • On March 12, Mehrotra sold 26,763 shares at $21.90 per share.
  • On March 13, Mehrotra sold 27,229 shares at $21.52 per share.

The players

Parth Mehrotra

The CEO of Privia Health Group, Inc.

Privia Health Group, Inc.

A healthcare technology company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee

The takeaway

This insider sale by Privia's CEO, while significant in size, is not necessarily a cause for alarm. Large stock sales by executives are common, especially after strong financial results. However, the transaction does provide insight into Mehrotra's personal financial planning and the stock's recent volatility, which investors will want to monitor going forward.